07-19-2013, 09:46 PM
<p class="">
<p class=""><i>GW Pharmaceuticals grows cannabis at an undisclosed location in southeast England. The company is testing a new diabetes drug made from a cannabis compound called THCV.</i>
<p style="color:rgb(68,68,68);font-family:helvetica, arial, sans-serif;">Tetrahydrocannabivarin (THCV) is just one of over 60 chemicals found in cannabis, but its unique activity has led GW Pharmaceuticals to believe that THCV could be the future of diabetes therapy.
<p style="color:rgb(68,68,68);font-family:helvetica, arial, sans-serif;">On Friday, the company who also manufacturers the cannabis spray Sativex toldBloombergabout their new drug, which showed promising results in a mid-stage clinical study, helping improve insulin production and lowering blood sugar levels, among other things, in patients with Type 2 diabetes. GW plans to publish the results later this year.
<p style="color:rgb(68,68,68);font-family:helvetica, arial, sans-serif;">GW has been funding research on THCV since 2005 and has alreadyfiled a patenton its use in the protection of pancreatic islet cells, which are the cells that produce insulin. At least 50% of these cells are lost by the time Type 2 diabetes is diagnosed.
Read whole story here:
http://www.truthonpot.com/2013/07/19/thc...-cannabis/
<p class=""><i>GW Pharmaceuticals grows cannabis at an undisclosed location in southeast England. The company is testing a new diabetes drug made from a cannabis compound called THCV.</i>
<p style="color:rgb(68,68,68);font-family:helvetica, arial, sans-serif;">Tetrahydrocannabivarin (THCV) is just one of over 60 chemicals found in cannabis, but its unique activity has led GW Pharmaceuticals to believe that THCV could be the future of diabetes therapy.
<p style="color:rgb(68,68,68);font-family:helvetica, arial, sans-serif;">On Friday, the company who also manufacturers the cannabis spray Sativex toldBloombergabout their new drug, which showed promising results in a mid-stage clinical study, helping improve insulin production and lowering blood sugar levels, among other things, in patients with Type 2 diabetes. GW plans to publish the results later this year.
<p style="color:rgb(68,68,68);font-family:helvetica, arial, sans-serif;">GW has been funding research on THCV since 2005 and has alreadyfiled a patenton its use in the protection of pancreatic islet cells, which are the cells that produce insulin. At least 50% of these cells are lost by the time Type 2 diabetes is diagnosed.
Read whole story here:
http://www.truthonpot.com/2013/07/19/thc...-cannabis/